Sequential azacitidine and lenalidomide in elderly acute myeloid leukemia: completed results of the phase I study

被引：0
|
作者：
Pollyea, D. A.
Kohrt, H. E.
Gallegos, L.
Zhang, B.
Figueroa, M.
Melnick, A.
Berube, C.
Coutre, S. E.
Gotlib, J. R.
Zehnder, J. L.
Liedtke, M.
Mitchell, B. S.
Medeiros, B. C.
机构：
[1] Stanford Canc Ctr, Stanford, CA USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6505
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6505
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase I Study of Sequential Azacitidine and Lenalidomide for Elderly Patients with Acute Myeloid Leukemia (AML)
    Pollyea, Daniel A.
    Kohrt, Holbrook E.
    Gallegos, Leonel
    Berube, Caroline
    Coutre, Steven
    Gotlib, Jason
    Liedtke, Michaela
    Mitchell, Beverly S.
    Medeiros, Bruno C.
    BLOOD, 2010, 116 (21) : 1347 - 1347
  • [2] Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
    Pollyea, Daniel A.
    Zehnder, James
    Coutre, Steve
    Gotlib, Jason R.
    Gallegos, Leonel
    Abdel-Wahab, Omar
    Greenberg, Peter
    Zhang, Bing
    Liedtke, Michaela
    Berube, Caroline
    Levine, Ross
    Mitchell, Beverly S.
    Medeiros, Bruno C.
    HAEMATOLOGICA, 2013, 98 (04) : 591 - 596
  • [3] An early-phase study of azacitidine and lenalidomide for untreated elderly acute myeloid leukemia (AML) patients
    Pollyea, D. A.
    Kohrt, H. E.
    Rajwanshi, R.
    Gallegos, L.
    Berube, C.
    Coutre, S. E.
    Gotlib, J. R.
    Liedtke, M.
    Mitchell, B. S.
    Medeiros, B. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
    D A Pollyea
    H E Kohrt
    L Gallegos
    M E Figueroa
    O Abdel-Wahab
    B Zhang
    S Bhattacharya
    J Zehnder
    M Liedtke
    J R Gotlib
    S Coutre
    C Berube
    A Melnick
    R Levine
    B S Mitchell
    B C Medeiros
    Leukemia, 2012, 26 : 893 - 901
  • [5] Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia
    Pollyea, D. A.
    Kohrt, H. E.
    Gallegos, L.
    Figueroa, M. E.
    Abdel-Wahab, O.
    Zhang, B.
    Bhattacharya, S.
    Zehnder, J.
    Liedtke, M.
    Gotlib, J. R.
    Coutre, S.
    Berube, C.
    Melnick, A.
    Levine, R.
    Mitchell, B. S.
    Medeiros, B. C.
    LEUKEMIA, 2012, 26 (05) : 893 - 901
  • [6] Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
    U Platzbecker
    F Braulke
    A Kündgen
    K Götze
    G Bug
    C Schönefeldt
    K Shirneshan
    C Röllig
    M Bornhäuser
    R Naumann
    J Neesen
    A Giagounidis
    W-K Hofmann
    G Ehninger
    U Germing
    D Haase
    M Wermke
    Leukemia, 2013, 27 : 1403 - 1407
  • [7] Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study
    Platzbecker, U.
    Braulke, F.
    Kuendgen, A.
    Goetze, K.
    Bug, G.
    Schoenefeldt, C.
    Shirneshan, K.
    Roellig, C.
    Bornhaeuser, M.
    Naumann, R.
    Neesen, J.
    Giagounidis, A.
    Hofmann, W-K
    Ehninger, G.
    Germing, U.
    Haase, D.
    Wermke, M.
    LEUKEMIA, 2013, 27 (06) : 1403 - 1407
  • [8] Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome
    Narayan, Rupa
    Garcia, Jacqueline S.
    Percival, Mary-Elizabeth M.
    Berube, Caroline
    Coutre, Steve
    Gotlib, Jason
    Greenberg, Peter
    Liedtke, Michaela
    Hewitt, Rhonda
    Regan, Kathleen
    Williamson, Charles
    Doykan, Camille
    Cardone, Michael H.
    McMillan, Alex
    Medeiros, Bruno C.
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 609 - 615
  • [9] A Final Report: Phase I/II Study of Sequential Azacitidine and Lenalidomide in Patients with Higher-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Daver, Naval
    Jabbour, Elias
    Kadia, Tapan
    Borthakur, Gautam
    Konopleva, Marina
    Pemmaraju, Naveen
    Yang, Hui
    Wei, Yue
    Wierda, William G.
    Bueso-Ramos, Carlos E.
    Patel, Keyur P.
    Cortes, Jorge E.
    Ravandi, Farhad
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2014, 124 (21)
  • [10] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2014, 124 (21)
12345